Ding, Yangfeng, and Weida Liu. “Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients With Moderate-to-Severe Plaque Psoriasis: A Matching-Adjusted Indirect Comparisons”. Acta Dermato-Venereologica, vol. 106, Apr. 2026, pp. adv-2025, doi:10.2340/actadv.v106.adv-2025-0183.